Publications by authors named "Roger Wermuth"

Claim this Profile
N
Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG Inhibition.
John G Cumming, Lukas Kreis, Holger Kühne, Roger Wermuth, Maarten Vercruysse

ACS Med Chem Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Series of Indane-Containing NBTIs with Activity against Multidrug-Resistant Gram-Negative Pathogens.
John G Cumming, Lukas Kreis, Holger Kühne, Roger Wermuth, Maarten Vercruysse

ACS Med Chem Lett· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.
Emmanuel Pinard, Daniela Alberati, Markus Bender, Edilio Borroni, Virginie Brom, Roger Wermuth

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, Markus Bender, Edilio Borroni, Roger Wermuth

J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis